RepaglinideA Review of its Therapeutic Use in Type 2 Diabetes Mellitus

被引:0
作者
Christine R. Culy
Blair Jarvis
机构
[1] Adis International limited,
来源
Drugs | 2001年 / 61卷
关键词
Metformin; Glycaemic Control; Glibenclamide; Troglitazone; Repaglinide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1625 / 1660
页数:35
相关论文
共 248 条
[1]  
Harris MI(1998)Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: the Third National Health and Nutrition Examination Survey, 1988–1994 Diabetes Care 21 518-24
[2]  
Flegal KM(1995)Epidemiology of type II diabetes: An international perspective Phannacoeconomics 8 1-11
[3]  
Cowie CC(1993)Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults WHO Ad Hoc Diabetes Reporting Group. Diabetes Care 16 157-77
[4]  
Songer TJ(1990)Epidemiology of diabetes mellitus among the elderly in the United States Clin GeriatrMed 6 703-19
[5]  
Zimmet PZ(1999)Pharmacologic therapy for type 2 diabetes mellitus Ann Intern Med 131 281-303
[6]  
King H(1998)Insulin resistance Endocr Rev 19 477-90
[7]  
Rewers M(1998) insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects Endocr Rev 19 491-503
[8]  
Harris MI(1988)The genetic basis of type 2 diabetes mellitus: impaired insulin secretion NEngl J Med 318 1231-9
[9]  
DeFronzo RA(1998) impaired insulin sensitivity Lancet 352 837-53
[10]  
Ferrannini E(1998)Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus Lancet 352 854-65